170 related articles for article (PubMed ID: 33483619)
1. Positive selection as the unifying force for clonal evolution in multiple myeloma.
Diamond B; Yellapantula V; Rustad EH; Maclachlan KH; Mayerhoefer M; Kaiser M; Morgan G; Landgren O; Maura F
Leukemia; 2021 May; 35(5):1511-1515. PubMed ID: 33483619
[No Abstract] [Full Text] [Related]
2. Multiple myeloma clonal evolution in homogeneously treated patients.
Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
[TBL] [Abstract][Full Text] [Related]
3. Clonal Evolution in Multiple Myeloma.
Fakhri B; Vij R
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
[TBL] [Abstract][Full Text] [Related]
4. Impact of Clonal Heterogeneity in Multiple Myeloma.
Schinke C; Rasche L; Raab MS; Weinhold N
Hematol Oncol Clin North Am; 2024 Apr; 38(2):461-476. PubMed ID: 38195308
[TBL] [Abstract][Full Text] [Related]
5. [Chromosomal abnormalities and clonal evolution in multiple myeloma].
Ishida T
Rinsho Ketsueki; 2014 Oct; 55(10):2036-45. PubMed ID: 25297769
[No Abstract] [Full Text] [Related]
6. Molecular basis of clonal evolution in multiple myeloma.
Furukawa Y; Kikuchi J
Int J Hematol; 2020 Apr; 111(4):496-511. PubMed ID: 32026210
[TBL] [Abstract][Full Text] [Related]
7. Hierarchy of mono- and biallelic
Munawar U; Rasche L; Müller N; Vogt C; Da-Via M; Haertle L; Arampatzi P; Dietrich S; Roth M; Garitano-Trojaola A; Steinhardt MJ; Strifler S; Gallardo M; Martinez-Lopez J; Bargou RC; Heckel T; Einsele H; Stühmer T; Kortüm KM; Barrio S
Blood; 2019 Sep; 134(10):836-840. PubMed ID: 31340981
[No Abstract] [Full Text] [Related]
8. Use of B-Cell Gene Rearrangement Studies to Establish Clonality in Non-producer Non-secretory Multiple Myeloma.
Mendoza H; Tormey CA; Siddon AJ
Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):e18-e21. PubMed ID: 31711890
[No Abstract] [Full Text] [Related]
9. Darwinian evolution and tiding clones in multiple myeloma.
Bahlis NJ
Blood; 2012 Aug; 120(5):927-8. PubMed ID: 22859708
[TBL] [Abstract][Full Text] [Related]
10. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing in tracking clonal evolution in multiple myeloma following therapy.
Weston-Bell N; Gibson J; John M; Ennis S; Pfeifer S; Cezard T; Ludwig H; Collins A; Zojer N; Sahota SS
Leukemia; 2013 Apr; 27(5):1188-91. PubMed ID: 23147253
[No Abstract] [Full Text] [Related]
12. Genomic complexity of multiple myeloma and its clinical implications.
Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
[TBL] [Abstract][Full Text] [Related]
13. The role of clonal evolution in smoldering multiple myeloma.
Bhatnagar V; Badros A
Leuk Lymphoma; 2014 Feb; 55(2):464-6. PubMed ID: 23865829
[No Abstract] [Full Text] [Related]
14. Clonal competition with alternating dominance in multiple myeloma.
Keats JJ; Chesi M; Egan JB; Garbitt VM; Palmer SE; Braggio E; Van Wier S; Blackburn PR; Baker AS; Dispenzieri A; Kumar S; Rajkumar SV; Carpten JD; Barrett M; Fonseca R; Stewart AK; Bergsagel PL
Blood; 2012 Aug; 120(5):1067-76. PubMed ID: 22498740
[TBL] [Abstract][Full Text] [Related]
15. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
[TBL] [Abstract][Full Text] [Related]
16. The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y; Mishima Y; Shirouchi Y; Nishimura N; Yokoyama M; Okabe T; Inoue N; Uryu H; Fukuta T; Hatake K; Terui Y
Int J Hematol; 2021 Feb; 113(2):279-284. PubMed ID: 32864713
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
Egan JB; Shi CX; Tembe W; Christoforides A; Kurdoglu A; Sinari S; Middha S; Asmann Y; Schmidt J; Braggio E; Keats JJ; Fonseca R; Bergsagel PL; Craig DW; Carpten JD; Stewart AK
Blood; 2012 Aug; 120(5):1060-6. PubMed ID: 22529291
[TBL] [Abstract][Full Text] [Related]
18. Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma.
Maura F; Rustad EH; Yellapantula V; Łuksza M; Hoyos D; Maclachlan KH; Diamond BT; Greenbaum BD; Morgan G; Lesokhin A; Papaemmanuil E; Landgren O
Leukemia; 2020 May; 34(5):1476-1480. PubMed ID: 31836853
[No Abstract] [Full Text] [Related]
19. BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation.
Bohn OL; Hsu K; Hyman DM; Pignataro DS; Giralt S; Teruya-Feldstein J
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):e65-8. PubMed ID: 24445188
[No Abstract] [Full Text] [Related]
20. Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.
Kortuem KM; Braggio E; Bruins L; Barrio S; Shi CS; Zhu YX; Tibes R; Viswanatha D; Votruba P; Ahmann G; Fonseca R; Jedlowski P; Schlam I; Kumar S; Bergsagel PL; Stewart AK
Blood Cancer J; 2016 Feb; 6(2):e397. PubMed ID: 26918361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
